AMG
GILD icon

Advisors Management Group’s Gilead Sciences GILD Stock Holding History

Advisors Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
2,521
-20,195
-89% -$2.66M 0.05% 136
2026
Q1 		$3.17M Sell
22,716
-5,389
-19% -$755K 0.58% 48
2025
Q4 		$3.45M Sell
28,105
-4,890
-15% -$594K 0.63% 46
2025
Q3 		$3.66M Sell
32,995
-471
-1% -$53.5K 0.64% 49
2025
Q2 		$3.71M Sell
33,466
-185
-0.5% -$19.7K 0.7% 45
2025
Q1 		$3.77M Sell
33,651
-90
-0.3% -$9.29K 0.82% 37
2024
Q4 		$3.12M Sell
33,741
-393
-1% -$35.4K 0.74% 43
2024
Q3 		$2.86M Sell
34,134
-173
-0.5% -$13.2K 0.68% 48
2024
Q2 		$2.35M Buy
34,307
+502
+1% +$33.5K 0.59% 57
2024
Q1 		$2.48M Buy
33,805
+725
+2% +$55.8K 0.61% 55
2023
Q4 		$2.68M Buy
33,080
+61
+0.2% +$4.75K 0.73% 44
2023
Q3 		$2.47M Buy
33,019
+173
+0.5% +$13.3K 0.75% 47
2023
Q2 		$2.53M Buy
32,846
+2,125
+7% +$169K 0.76% 45
2023
Q1 		$2.55M Sell
30,721
-230
-0.7% -$19.1K 0.81% 43
2022
Q4 		$2.66M Sell
30,951
-196
-0.6% -$15.5K 1% 35
2022
Q3 		$1.92M Buy
31,147
+172
+0.6% +$10.8K 0.76% 47
2022
Q2 		$1.92M Buy
+30,975
New +$1.92M 0.67% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisors Management Group's GILD Position: Q2 2026 in Review

Advisors Management Group reduced its Gilead Sciences (GILD) stake by 89% in Q2 2026, selling an estimated $2.66M and leaving 2,521 shares worth $318K. The position accounts for 0.05% of the portfolio, ranked #136.

Advisors Management Group first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.77M in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Advisors Management Group held 2,521 shares of Gilead Sciences worth $318K as of Q2 2026.
  • Advisors Management Group sold 20,195 Gilead Sciences shares in Q2 2026, an estimated $2.66M.
  • Gilead Sciences made up 0.05% of Advisors Management Group's portfolio in Q2 2026, its #136 holding.
  • Advisors Management Group first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Advisors Management Group's Gilead Sciences position peaked at $3.77M in Q1 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Advisors Management Group's 13F filing for Q2 2026, filed 4 Aug 2026.